FEB 07, 2017 6:05 PM PST

Structure of new Antibiotic Shown to be Relevant to Mode of Action

WRITTEN BY: Carmen Leitch

A new antibiotic, teixobactin, was identified a few years ago. It can kill bacteria and has not been shown resistance by pathogens. It's the first new drug taken from bacteria in many years, and seems to represent a new class of drugs. Revealing more about how it works could aid researcher striving to develop more drugs that can tackle antibiotic resistant superbugs, an emerging public health threat. A team working at the University of Lincoln, UK, has had past success creating two synthetic derivatives of teixobactin. That research group has now reported the molecular architecture of the teixobactin molecule in the the Royal Society of Chemistry journal, Chemical Communications.

Certain residues maintain a reasonably unstructured teixobactin which is imperative for biological activity / Credit: Chemical Communications

"The increasing level of antimicrobial resistance represents a major global health challenge. The discovery of the highly potent antibiotic teixobactin to cope with this growing problem has provided a much-needed impetus to antibiotic research around the world. Although teixobactin does not mitigate all problems related to antimicrobial resistance, it is a definite step in the right direction, and our research continues to work towards this vital end goal," explained team leader Dr. Ishwar Singh, of he School of Pharmacy at University of Lincoln, UK.

U.S. investigators found teixobactin in microbes that live in soil in 2015. Soil has been a rich resource for antibiotics since the 1940s. However, it's not practical to use soil to make antibiotics on a large scale; scientists have to develop methods for manufacturing these molecules so they will be useful on a large scale. This new work characterizing the structure of the molecule also provides some insight into its mode of action, and it has demonstrated powerful efficacy in mice. Researchers are working on getting it to use in humans, and this work helps pave the way.

The research team found that the antimicrobial efficacy of teixobactin is directly connected to its lack of a rigid structure. The relatively unstructured nature of the molecule is critical to how it works on the biological level. This has been confirmed by the lack of effectiveness seen in more structured types of the teixobactin antibiotic. The scientists also figured out a way to retain flexibility in the molecule through the creation of chemical derivatives. "We successfully defined the molecular structure of seven teixobactin analogues," said Singh. "This enabled us to understand the importance of the individual amino acids within the antibiotic, and to understand the contribution they each make to the molecular structures of teixobactin. We found that one particular amino acid (D-Gln) is essential and another (D-Ile) is important for maintaining the disordered structure of teixobactin, which is imperative for its biological activity."

 "By exploring the structures of different versions of teixobactin we are, for the first time, able to begin to understand how this molecule works. This knowledge will enable us to produce different forms of teixobactin more easily and on a larger scale with potentially better pharmaceutical properties," commented Taylor.

Hear more about the teixobactin antibiotic in the following video.

 

Sources: AAAS/Eurekalert via University of Lincoln, Chemical Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 28, 2019
Chemistry & Physics
NOV 28, 2019
Wave-Matter Duality Observed on a Biological Macromolecule for the First Time
Quantum physics tells us about the properties and behaviors of particles in the atomic and subatomic world. But scientists have long held the belief that t...
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
DEC 09, 2019
Cell & Molecular Biology
DEC 09, 2019
Newly IDed Biomarker Can Predict Compulsive Drinking
Lots of people drink alcohol, but not everyone develops a drinking problem. Researchers are starting to learn more about why that is....
DEC 18, 2019
Drug Discovery & Development
DEC 18, 2019
Stroke Drug Enhances Stem Cell Therapies for Spinal Cord Injuries
Using rat models of spinal cord injuries, Yasuhiro Shiga, MD, PhD, thought treating them with stem cell therapy would point to nowhere but the nature of re...
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
A Molecular Switch for Modulating Gene Therapy Doses
  Genetic errors cause many different kinds of diseases, and gene therapy has aimed to relieve those symptoms by addressing the root cause....
DEC 30, 2019
Neuroscience
DEC 30, 2019
Amyloid Plaques May Not Come First in Alzheimer's
It’s commonly thought that excessive build-up of amyloid plaques, destroying the connections between nerve cells, is the first sign of Alzheimer&rsqu...
Loading Comments...